Ultragenyx Pharmaceutical
RARE
RARE
297 hedge funds and large institutions have $3.22B invested in Ultragenyx Pharmaceutical in 2025 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 125 increasing their positions, 104 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
4% less funds holding
Funds holding: 310 → 297 (-13)
13% less capital invested
Capital invested by funds: $3.68B → $3.22B (-$462M)
23% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 44
Holders
297
Holding in Top 10
7
Calls
$43.9M
Puts
$42.2M
Top Buyers
| 1 | +$35M | |
| 2 | +$31.6M | |
| 3 | +$25.6M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$25.2M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$23.6M |
Top Sellers
| 1 | -$36.2M | |
| 2 | -$26M | |
| 3 | -$19.1M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$17.6M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$13.8M |
